Helen Mccarthy PhD

Dr Helen McCarthy obtained her PhD in 2000 from University of Ulster, Jordanstown. She then took a Research Associate post in the field of prostate cancer gene therapy at the University of Ulster. In July 2004 she moved to the School of Pharmacy, Queen's University to take the post of Research Fellow on a cancer gene therapy project, within the newly established, Experimental Therapeutics research cluster. She obtained a lectureship within the School of Pharmacy in November 2006, then Senior Lecturer in 2011 and Reader in 2013. Her main research focus is the development of bio-inspired delivery systems for nanomedical applications. To that end, she has 2 patents, published over 60 scientific publications, edited a book and has given many conference presentations.

She has received research grant income from the National Science Foundation, Invest Northern Ireland, Cancer Research UK, Breast Cancer Campaign, Prostate Cancer UK, Royal Pharmaceutical Society of Great Britain, The Royal Society, BBSRC, MRC, Prostate Cancer Research Foundation and Action Cancer. She is a member of the Association for Radiation Research, British Society for Gene Therapy, the American Nano Society and European Society of Biomaterials. She is also on the editorial board for Cancer Nanotechnology and an external examiner at RCSI.